Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T01575 | ||||
Target Name | Sphingosine 1 phosphate lyase 1 | ||||
Synonyms | S1PL; SP-lyase 1; SPL 1; Sphingosine-1-phosphate aldolase; hSPL; SGPL1 | ||||
Target Type | Clinical Trial | ||||
Gene Name | SGPL1 {ECO:0000312|HGNC:HGNC:10817}||Synonyms=KIAA1252 {ECO:0000303|PubMed:10574462} | ||||
Biochemical Class | Carbon-carbon lyase | ||||
UniProt ID | SGPL1_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Rheumatoid arthritis | ||||
Example drug | LX2931 | Phase 2 | [522666], [1572592] | ||
Tissue | Synovial tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.38 Z-score: 0.90 P-value: 1.63E-02 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.